| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Mueller Peter is a Director at BioXcel Therapeutics, Inc.. Recent SEC Form 4 filings include 12 buys and 0 sells.
Estimated insider holdings value: $200K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 23, 2019 | BTAI Bioxcel Therapeutics, Inc. | Director | Buy | 1,554 | $9.34 | $14,514.36 | +0.9% | |
| Aug 22, 2019 | BTAI Bioxcel Therapeutics, Inc. | Director | Buy | 8,446 | $8.74 | $73,840.18 | +2.7% | |
| Dec 7, 2018 | BTAI Bioxcel Therapeutics, Inc. | Director | Buy | 8,795 | $5.01 | $44,045.05 | +1.5% | |
| Dec 4, 2018 | BTAI Bioxcel Therapeutics, Inc. | Director | Buy | 4,007 | $5.13 | $20,544.17 | +0.5% |